title: The effect of high dose radioiodine therapy on formation of radiation retinopathy during thyroid cancer treatment.
abstract: OBJECTIVE
  Non-thyroidal complication of high-dose radioiodine therapy for thyroid carcinoma might cause salivary and lacrimal gland dysfunction, which may be transient or permanent in a dose-dependent manner. However, radiation retinopathy complicating 131I therapy, has not been previously well characterized. The aim of this study was to evaluate the extent of retinal damage among patients who had received high doses of radioiodine treatment.
  
  
  METHODS
  Forty eyes of 20 patients (3 male, 17 female) who received 250-1000 mCi during 131I therapy and on ophthalmological follow up for a year after the last treatment were included in the study. Mean age of the study group was 50 years (range 25-70 years). In ophthalmologic examination, visual acuity was measured in order to determine visual loss. Intraocular pressure was measured in all the patients. Then lens examination was carried out with slit lamp biomicroscopy in order to investigate cataract or partial lens opacities. Fundus observation was carried out through the dilated pupil with slit lamp biomicroscopy using 90 D noncontact lens.
  
  
  RESULTS
  The best corrected visual aquity with Snellen chart was found as 1.0 in 36 eyes (90%) and between 0.6 and 0.9 (10%) in 4 eyes (10%). At the biomicroscopic fundus examination, retinal hemorrhage consistent with radiation retinopathy, microaneurysm, microinfarction, edema or exudation, vitreus hemorrhage, partial or total optical disc pallor indicating papillopathy in the optic disc were not observed in any of the eyes.
  
  
  CONCLUSIONS
  This result indicates that there is not any significant correlation between repeated high-dose radioiodine therapy and radiation retinopathy in differentiated thyroid carcinomas. Even though there is not a significant restriction in use of higher doses of radioiodine therapy in differentiated thyroid carcinoma, more extensive studies are needed in order to obtain more accurate data on possible occurrence of retinopathy.
authors.affiliation: Konya Training and Research Hospital, Clinic of Nuclear Medicine, Konya, Turkey. E-ma-il: drtulay2004@yahoo.com.
authors.forename: Tülay
authors.initials: T
authors.lastname: Kaçar Güveli
authors.forename: Sezer
authors.initials: S
authors.lastname: Özkan
authors.forename: Müge
authors.initials: M
authors.lastname: Öner Tamam
authors.forename: Ercan
authors.initials: E
authors.lastname: Uyanık
authors.forename: Nurcan
authors.initials: N
authors.lastname: Ediz
authors.forename: Mehmet
authors.initials: M
authors.lastname: Mülazımoğlu
authors.forename: Tevfik
authors.initials: T
authors.lastname: Özpaçacı